SLIDESHOW: Top 25 Socially Responsible Dividend Stocks
By Dividend Channel Staff, updated Sat, January 18, 12:57 AM
This Slide: #1 of 25 |
#25. Gilead Sciences Inc (NASDAQ:GILD) — 3.36% Yield
Gilead Sciences is a biopharmaceutical company focused on advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Co. emphasizes the discovery, development, and commercialization of medicines for unmet medical needs. Its marketed products include AmBisome, Atripla, Biktarvy, Descovy (including for PrEP), Epclusa, Genvoya, Harvoni, Sovaldi, Truvada (including for PrEP), Veklury, Vemlidy, Viread, Yescarta, and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Domvanalimab, Zimberelimab, and Seladelpar for treating primary biliary cholangitis (PBC). Co. operates in over 35 countries.
GILD is found in these ETFs: KLD, DSI, more View GILD's Dividend History at Dividend Channel »
|
Open the Dividend Channel GILD Page (in a new window) »
GILD Next Dividend Date » (Projection based upon history) GILD Dividend Growth Rate » Quotes delayed 20 minutes |
Buy (3.17 out of 4) 39th percentile
(ranked lower than approx. 61% of all stocks covered)
Analysts' Target Price: GILD Forecast Based on data provided by Zacks Investment Research via Quandl.com |
|